Search filters

List of works by Isabelle Navarro-Teulon

A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy.

scientific article published on 11 June 2009

Anti-HER2 vaccines: new prospects for breast cancer therapy

scientific article

Anti-MISRII radiolabeled antibodies: new tools for a theranostic approach in ovarian cancer

scientific article published on 19 April 2018

Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models

scientific article published on 2 November 2017

Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membrane.

scientific article published on 19 March 2013

Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies.

scientific article

Clinical radioimmunotherapy--the role of radiobiology.

scientific article

Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb

scientific article

DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy.

scientific article published on 6 February 2014

Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy

scientific article published on 06 May 2019

General overview of radioimmunotherapy of solid tumors

scientific article published on May 2013

High level prokaryotic expression of anti-Müllerian inhibiting substance type II receptor diabody, a new recombinant antibody for in vivo ovarian cancer imaging.

scientific article published on 14 August 2012

Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies

scientific article published on 04 February 2019

In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas

scientific article published on June 2007

Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer

scientific article published on 12 June 2011

Introduction to radiobiology of targeted radionuclide therapy

scientific article

Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.

scientific article

Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects

scientific article published on 25 May 2016

Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.

scientific article published on 7 November 2007

Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis

scientific article published on 12 November 2009

Optimization of IEDDA bioorthogonal system: Efficient process to improve trans-cyclooctene/tetrazine interaction

scientific article published on 15 July 2020

Peptides derived from the two regulatory domains of p53 are recognized by two p53-activating antibodies ⬇️

scientific article published on 01 March 2003

Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers

scientific article published on 25 September 2013

Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept

scientific article published on 19 September 2019

Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice

scientific article published on 01 November 2007

Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein.

scientific article published on 11 September 2008

Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients.

scientific article

Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer

scientific article

The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand

scientific article

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells

scientific article

The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.

scientific article

The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages.

scientific article published on 7 October 2017

The lipid-modulating effects of a CD4-specific recombinant antibody correlate with ZAP-70 segregation outside membrane rafts

scientific article published on 24 July 2010

The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest

scientific article published on 13 December 2019

Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice. ⬇️

scientific article

[Combination of anti-EGFR and anti-HER2 antibodies: hope in pancreatic cancer treatment]

scientific article published on 01 October 2007

[Combined anti-EGFR and anti-HER2 monoclonal antibodies: preclinical efficacy in the treatment of pancreatic cancer]

scientific article published on 01 October 2007

Paulina is supported by:

About Paulina

Help